What is Adbry?
Adbry is the brand name for tralokinumab, a medicine used to treat certain inflammatory skin diseases, especially moderate-to-severe atopic dermatitis (eczema) in people whose condition is not controlled well with other treatments. [1]
How does Adbry work?
Adbry (tralokinumab) is an antibody that targets interleukin-13 (IL-13), a protein involved in inflammation in atopic dermatitis. By blocking IL-13 signaling, it helps reduce eczema symptoms such as redness, itching, and skin irritation. [1]
What conditions is it used for?
Adbry is used for moderate-to-severe atopic dermatitis in appropriate patients (typically adults, based on prescribing information). [1]
How is Adbry taken?
Adbry is given as an injection (usually by patients or caregivers after training). Dosing and whether it is administered as a loading phase then maintenance dosing depend on the prescribed regimen. [1]
What side effects do people ask about?
Common side effects of biologic eczema treatments often include injection-site reactions and conjunctivitis/eye irritation; exact risks depend on the product’s labeled side effects and the patient’s medical history. [1]
Is Adbry a steroid or a biologic?
Adbry is not a steroid. It is a biologic (monoclonal antibody) medicine. [1]
Where can I read the official details?
For the most accurate guidance on indications, dosing, contraindications, and side effects, check the FDA label or the product prescribing information for tralokinumab (Adbry). [1]
Sources:
[1] https://www.adbry.com/